Our Technology

Drug and materials discovery pipelines

In addition to working with other companies, SoftMining has achieved important results in many areas. As you can see, we are active in the development of antibiotics, anticancer drugs, and biomaterials.

Disease model

Early discovery

Discovery

Preclinical

Phase 1

Phase 2

Bacteria 1* 60%
Bacteria 2* 41%
ADAR* 44%

Biomaterials

Early discovery

Discovery

Preclinical

Phase 1

Phase 2

Biodegradable controlled materials * 100%
Chemical synthesis on metal support 40%
Biodegradable non toxic PVC replacement * 45%
Electrochemical treatment of bacteriosys * 30%

APPs pipeline

This represents a side effect of SoftMining research. It all started with the Covid emergency. SoftMining proposed and built (in team with other startups) the first European contact tracing app SM-Covid-19We were present on Google and Apple stores since April 2020 thanks to the support of Regione Campania (Italy). We filed two patents related to Bluetooth technologies and developed, in record time, multiplatform solutions to support communities in containing the virus. 
These assets can be sourced or licensed to other companies.

Type

App

Download

Idea

IP rights

Prototype

Beta release

Market

Funding

BLE contact tracing

> 0
100%

NA

Tourism assistant

WIT

> 0
80%

Risk assessment

Convivio

> 0
80%

Social platform

WIT+

60%

Sep 2021

Electrocardiogram analysis

EKG

Web

78%

Semantic analysis

Web

60%